liver/biliary system
|
• mice show metabolic dysfunction-associated steatohepatitis, including microsteatosis, Mallory-Denk bodies, and atypical nuclei in zone 3 area, indicating liver steatosis without signs of cholestasis
|
|
• mice show metabolic dysfunction-associated steatohepatitis, including microsteatosis
|
|
• perisinusoidal fibrosis in zone 3
|
|
• carnitine palmitoyltransferase activity of 8-week-old livers is reduced suggesting that fatty acid metabolism is impaired
|
|
• mice show metabolic dysfunction-associated steatohepatitis
|
homeostasis/metabolism
|
• serum alpha-fetoprotein is increased
|
immune system
|
• mice show metabolic dysfunction-associated steatohepatitis
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
| metabolic dysfunction-associated steatohepatitis | DOID:0080547 | J:371295 | ||


Analysis Tools